Orphalan becomes the first European company to enter in China’s Wilson Disease market

Strategic partnership with Kyuan Xinhai (Beijing) Medical Products Trade Co., Ltd (“SPH Kyuan Trade”) to transform access to Wilson’s disease treatment for Chinese patients PARIS, March 7, 2025 /PRNewswire/ — Orphalan, a global pioneer in orphan drug development and commercialization,…